Author

G. Cavalleri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Campbell· 2 shared A. Jorgensen· 1 shared A. Kissenpfennig· 1 shared A. Marson· 1 shared A. Short· 1 shared A. Yakkundi· 1 shared B. P. Koeleman· 1 shared C. Depondt· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

C. Campbell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Polygenic risk score analysis reveals shared genetic burden between epilepsy and psychiatric comorbidities

C. Campbell, D. Lewis-Smith, C. Leu, H. Martins, S. Wolking, R. Krause, T. J. O'Brien, G. Sills, F. Zara, B. P. Koeleman, C. Depondt, A. Marson, H. Stefansson, K. Stefansson, J. Craig, , G. Cavalleri

This study uses polygenic risk scores to show that people with epilepsy have increased genetic risk for depression, psychosis, and ADHD, with stronger associations in drug-resistant cases.

medRxiv · Jul 4, 2023 · PreprintGenetic & Genomic Medicine

The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-kappaB signaling

S. L. Annett, S. Spence, C. Garciarena, C. Campbell, M. Dennehy, C. Drakeford, J. Lai, J. Dowling, G. Moore, A. Yakkundi, A. Short, D. Sharpe, F. Furlong, J. O'Donnell, G. Cavalleri, , T. Robson

This paper identifies FKBPL and its peptides as regulators of vascular integrity and inflammation via NF-kappaB signaling, showing therapeutic potential in inflammatory diseases.

bioRxiv · Feb 24, 2021 · PreprintImmunology